{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:17:27Z","timestamp":1787732247509,"version":"build-2784847793"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Foundation of Liaoning Province Education Administration"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41417-026-01065-0","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T07:59:02Z","timestamp":1786348742000},"page":"1069-1080","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LncRNA PCAT7 drives tumorigenesis and glycolytic reprogramming in breast cancer via the ceRNA-mediated miR-204-5p\/RUNX2 axis"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5934-6793","authenticated-orcid":false,"given":"Pengxiang","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6851-3744","authenticated-orcid":false,"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongxuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1786-9154","authenticated-orcid":false,"given":"Xiaofeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"1065_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1065_CR2","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","volume":"389","author":"N Harbeck","year":"2017","unstructured":"Harbeck N, Gnant M. Breast cancer. Lancet. 2017;389:1134\u201350.","journal-title":"Lancet"},{"key":"1065_CR3","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"1065_CR4","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"1065_CR5","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s43018-024-00775-4","volume":"5","author":"KM Tharp","year":"2024","unstructured":"Tharp KM, Kersten K, Maller O, Timblin GA, Stashko C, Canale FP, et al. Tumor-associated macrophages restrict CD8(+) T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment. Nat Cancer. 2024;5:1045\u201362.","journal-title":"Nat Cancer"},{"key":"1065_CR6","doi-asserted-by":"publisher","first-page":"89.","DOI":"10.3390\/cells8020089","volume":"8","author":"N Gandhi","year":"2019","unstructured":"Gandhi N, Das GM. Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications. Cells. 2019;8:89.","journal-title":"Cells"},{"key":"1065_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia L, Oyang L, Lin J, Tan S, Han Y, Wu N, et al. The cancer metabolic reprogramming and immune response. Mol Cancer. 2021;20:28.","journal-title":"Mol Cancer"},{"key":"1065_CR8","doi-asserted-by":"publisher","first-page":"285.","DOI":"10.3390\/cancers14020285","volume":"14","author":"HJ Lin","year":"2022","unstructured":"Lin HJ, Liu Y, Lofland D, Lin J. Breast Cancer Tumor Microenvironment and Molecular Aberrations Hijack Tumoricidal Immunity. Cancers. 2022;14:285.","journal-title":"Cancers"},{"key":"1065_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00018-015-2070-4","volume":"73","author":"Z Li","year":"2016","unstructured":"Li Z, Zhang H. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol Life Sci. 2016;73:377\u201392.","journal-title":"Cell Mol Life Sci"},{"key":"1065_CR10","doi-asserted-by":"crossref","unstructured":"Chelakkot C, Chelakkot VS, Shin Y, Song K. Modulating Glycolysis to Improve Cancer Therapy. Int J Mol Sci. 2023;24.","DOI":"10.3390\/ijms24032606"},{"key":"1065_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-152","volume":"12","author":"S Ganapathy-Kanniappan","year":"2013","unstructured":"Ganapathy-Kanniappan S, Geschwind JF. Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer. 2013;12:152.","journal-title":"Mol Cancer"},{"key":"1065_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7007-8-88","volume":"8","author":"JW Locasale","year":"2010","unstructured":"Locasale JW, Cantley LC. Altered metabolism in cancer. BMC Biol. 2010;8:88.","journal-title":"BMC Biol"},{"key":"1065_CR13","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrc.2016.77","volume":"16","author":"N Hay","year":"2016","unstructured":"Hay N. Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat Rev Cancer. 2016;16:635\u201349.","journal-title":"Nat Rev Cancer"},{"key":"1065_CR14","doi-asserted-by":"publisher","first-page":"4245.","DOI":"10.3390\/nu15194245","volume":"15","author":"MTJ Halma","year":"2023","unstructured":"Halma MTJ, Tuszynski JA, Marik PE. Cancer Metabolism as a Therapeutic Target and Review of Interventions. Nutrients. 2023;15:4245.","journal-title":"Nutrients"},{"key":"1065_CR15","doi-asserted-by":"publisher","first-page":"703","DOI":"10.4161\/rna.20481","volume":"9","author":"T Gutschner","year":"2012","unstructured":"Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9:703\u201319.","journal-title":"RNA Biol"},{"key":"1065_CR16","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2217\/fon-2020-0273","volume":"17","author":"J Zhou","year":"2021","unstructured":"Zhou J, Zhang S, Luo M. LncRNA PCAT7 promotes the malignant progression of breast cancer by regulating ErbB\/PI3K\/Akt pathway. Future Oncol. 2021;17:701\u201310.","journal-title":"Future Oncol"},{"key":"1065_CR17","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1038\/s41388-021-01859-6","volume":"40","author":"S Zhao","year":"2021","unstructured":"Zhao S, Guan B, Mi Y, Shi D, Wei P, Gu Y, et al. LncRNA MIR17HG promotes colorectal cancer liver metastasis by mediating a glycolysis-associated positive feedback circuit. Oncogene. 2021;40:4709\u201324.","journal-title":"Oncogene"},{"key":"1065_CR18","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon A, Subramanian A, Pinchback R, Thorvaldsd\u00f3ttir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27:1739\u201340.","journal-title":"Bioinformatics"},{"key":"1065_CR19","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/bioinformatics\/btg114","volume":"19","author":"CI Castillo-Davis","year":"2003","unstructured":"Castillo-Davis CI, Hartl DL. GeneMerge-post-genomic analysis, data mining, and hypothesis testing. Bioinformatics. 2003;19:891\u20132.","journal-title":"Bioinformatics"},{"key":"1065_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","volume":"7","author":"RJ DeBerardinis","year":"2008","unstructured":"DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7:11\u201320.","journal-title":"Cell Metab"},{"key":"1065_CR21","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029\u201333.","journal-title":"Science"},{"key":"1065_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13045-019-0773-y","volume":"12","author":"Q Hua","year":"2019","unstructured":"Hua Q, Jin M, Mi B, Xu F, Li T, Zhao L, et al. LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p\/c-Myc axis. J Hematol Oncol. 2019;12:91.","journal-title":"J Hematol Oncol"},{"key":"1065_CR23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.semcancer.2022.11.007","volume":"87","author":"D Sharma","year":"2022","unstructured":"Sharma D, Singh M, Rani R. Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics. Semin Cancer Biol. 2022;87:184\u201395.","journal-title":"Semin Cancer Biol"},{"key":"1065_CR24","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"Brand A, Singer K, Koehl GE, Kolitzus M, Schoenhammer G, Thiel A, et al. LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells. Cell Metab. 2016;24:657\u201371.","journal-title":"Cell Metab"},{"key":"1065_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.molcel.2021.11.026","volume":"82","author":"HO Iwakawa","year":"2022","unstructured":"Iwakawa HO, Tomari Y. Life of RISC: Formation, action, and degradation of RNA-induced silencing complex. Mol Cell. 2022;82:30\u201343.","journal-title":"Mol Cell"},{"key":"1065_CR26","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505:344\u201352.","journal-title":"Nature"},{"key":"1065_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"1065_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Sci Adv. 2016;2:e1600200.","journal-title":"Sci Adv"},{"key":"1065_CR29","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","volume":"13","author":"G Kroemer","year":"2008","unstructured":"Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer\u2019s Achilles\u2019 heel. Cancer Cell. 2008;13:472\u201382.","journal-title":"Cancer Cell"},{"key":"1065_CR30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","volume":"21","author":"PS Ward","year":"2012","unstructured":"Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell. 2012;21:297\u2013308.","journal-title":"Cancer Cell"},{"key":"1065_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18195","volume":"28","author":"XS Liu","year":"2024","unstructured":"Liu XS, Zhang Y, Liu ZY, Gao Y, Yuan LL, Zeng DB, et al. METTL3 as a novel diagnosis and treatment biomarker and its association with glycolysis, cuproptosis and ceRNA in oesophageal carcinoma. J Cell Mol Med. 2024;28:e18195.","journal-title":"J Cell Mol Med"},{"key":"1065_CR32","doi-asserted-by":"publisher","first-page":"853596","DOI":"10.3389\/fcell.2022.853596","volume":"10","author":"XS Liu","year":"2022","unstructured":"Liu XS, Yang JW, Zeng J, Chen XQ, Gao Y, Kui XY, et al. SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA. Front Cell Dev Biol. 2022;10:853596.","journal-title":"Front Cell Dev Biol"},{"key":"1065_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11447-8","volume":"10","author":"J Tang","year":"2019","unstructured":"Tang J, Yan T, Bao Y, Shen C, Yu C, Zhu X, et al. LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc. Nat Commun. 2019;10:3499.","journal-title":"Nat Commun"},{"key":"1065_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13046-022-02285-6","volume":"41","author":"Y Hu","year":"2022","unstructured":"Hu Y, Tang J, Xu F, Chen J, Zeng Z, Han S, et al. A reciprocal feedback between N6-methyladenosine reader YTHDF3 and lncRNA DICER1-AS1 promotes glycolysis of pancreatic cancer through inhibiting maturation of miR-5586-5p. J Exp Clin Cancer Res. 2022;41:69.","journal-title":"J Exp Clin Cancer Res"},{"key":"1065_CR35","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/1878-0261.12634","volume":"14","author":"C Lang","year":"2020","unstructured":"Lang C, Dai Y, Wu Z, Yang Q, He S, Zhang X, et al. SMAD3\/SP1 complex-mediated constitutive active loop between lncRNA PCAT7 and TGF-\u03b2 signaling promotes prostate cancer bone metastasis. Mol Oncol. 2020;14:808\u201328.","journal-title":"Mol Oncol"},{"key":"1065_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0874-1","volume":"17","author":"XZ Yang","year":"2018","unstructured":"Yang XZ, Cheng TT, He QJ, Lei ZY, Chi J, Tang Z, et al. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt\/\u03b2-catenin pathway. Mol Cancer. 2018;17:126.","journal-title":"Mol Cancer"},{"key":"1065_CR37","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.bbrc.2017.07.093","volume":"491","author":"Y Liu","year":"2017","unstructured":"Liu Y, Tao Z, Qu J, Zhou X, Zhang C. Long non-coding RNA PCAT7 regulates ELF2 signaling through inhibition of miR-134-5p in nasopharyngeal carcinoma. Biochem Biophys Res Commun. 2017;491:374\u201381.","journal-title":"Biochem Biophys Res Commun"},{"key":"1065_CR38","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2011.09.029","volume":"147","author":"Y Tay","year":"2011","unstructured":"Tay Y, Kats L, Salmena L, Weiss D, Tan SM, Ala U, et al. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell. 2011;147:344\u201357.","journal-title":"Cell"},{"key":"1065_CR39","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.molcel.2019.02.008","volume":"73","author":"J Carlevaro-Fita","year":"2019","unstructured":"Carlevaro-Fita J, Johnson R. Global Positioning System: Understanding Long Noncoding RNAs through Subcellular Localization. Mol Cell. 2019;73:869\u201383.","journal-title":"Mol Cell"},{"key":"1065_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01747-5","volume":"22","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Dong X, Guo X, Li C, Fan Y, Liu P, et al. LncRNA-BC069792 suppresses tumor progression by targeting KCNQ4 in breast cancer. Mol Cancer. 2023;22:41.","journal-title":"Mol Cancer"},{"key":"1065_CR41","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.7150\/ijbs.82875","volume":"19","author":"SS Liu","year":"2023","unstructured":"Liu SS, Li JS, Xue M, Wu WJ, Li X, Chen W. LncRNA UCA1 Participates in De Novo Synthesis of Guanine Nucleotides in Bladder Cancer by Recruiting TWIST1 to Increase IMPDH1\/2. Int J Biol Sci. 2023;19:2599\u2013612.","journal-title":"Int J Biol Sci"},{"key":"1065_CR42","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1111\/cas.15581","volume":"113","author":"D Fang","year":"2022","unstructured":"Fang D, Ou X, Sun K, Zhou X, Li Y, Shi P, et al. m6A modification-mediated lncRNA TP53TG1 inhibits gastric cancer progression by regulating CIP2A stability. Cancer Sci. 2022;113:4135\u201350.","journal-title":"Cancer Sci"},{"key":"1065_CR43","doi-asserted-by":"crossref","unstructured":"Urz\u00ec O, Gasparro R, Costanzo E, De Luca A, Giavaresi G, Fontana S, et al. Three-Dimensional Cell Cultures: The Bridge between In Vitro and In Vivo Models. Int J Mol Sci. 2023;24.","DOI":"10.3390\/ijms241512046"},{"key":"1065_CR44","doi-asserted-by":"publisher","first-page":"1145.","DOI":"10.3390\/ijms24021145","volume":"24","author":"V Melone","year":"2023","unstructured":"Melone V, Salvati A, Brusco N, Alexandrova E, D\u2019Agostino Y, Palumbo D, et al. Functional Relationships between Long Non-Coding RNAs and Estrogen Receptor Alpha: A New Frontier in Hormone-Responsive Breast Cancer Management. Int J Mol Sci. 2023;24:1145.","journal-title":"Int J Mol Sci"},{"key":"1065_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188491","volume":"1875","author":"S Toden","year":"2021","unstructured":"Toden S, Zumwalt TJ, Goel A. Non-coding RNAs and potential therapeutic targeting in cancer. Biochim Biophys Acta Rev Cancer. 2021;1875:188491.","journal-title":"Biochim Biophys Acta Rev Cancer"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01065-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01065-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01065-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:17:43Z","timestamp":1787728663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01065-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1065"],"URL":"https:\/\/doi.org\/10.1038\/s41417-026-01065-0","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}